4.8 (287) · $ 9.00 · In stock

Description

Merck, Ridgeback clinch FDA's 2nd emergency nod for a COVID-19

U.K. 1st country to authorize use of Merck's coronavirus antiviral

Most Americans not worrying about COVID going into 2022 Holidays

Drugmaker Merck unit seeks approval of 1st oral COVID drug in Japan

Merck seeks FDA emergency use authorization for experimental

Here's How Merck Is Making Their COVID Antiviral Drug Accessible

COVID-19 antivirals: Canada authorizes at-home Pfizer treatment

India warns against use of 'game-changing' Covid antiviral over

Behind a New Pill to Treat Covid: A Husband-and-Wife Team and a

Why Cheap, Older Drugs That Might Treat Covid Never Get Out of the

Frontiers Mechanism of Action of Small-Molecule Agents in

Pfizer's Covid-19 Pill Is Authorized in U.S. - WSJ

Antiviral efficacy of molnupiravir versus ritonavir-boosted